Supplemental Methods

Analysis of KIF11 expression and localization in the adult murine retina
Animals: C57BL/6J mice were maintained under a 12-hour light-dark cycle, with food and water ad libitum. All experiments with animals were conform to the statement by the Association for Research in Vision and Ophthalmology (ARVO) as to care and use of animals in research.
After sacrifice, eyeballs and testes from adult mice were dissected and processed for follow-up analysis. For Western blot analysis, we performed a previously published protocol. 1 In brief, mouse retina samples were lysed in RIPA lysis buffer, eluted with SDS-sample buffer and subjected to SDS-PAGE. Proteins were transferred to polyvinylidene difluoride membranes (Millipore, Schwalbach, Germany). After blocking, polyclonal antibodies against KIF11 generated against recombinant human KIF11 aa 637-784 epitope, extending from the neck region We performed the previously published protocol for pre-embedding labeling immunoelectron microscopy. 3 In brief, vibratome sections through the murine retina were incubated with primary antibodies for 90 h before applying the biotinylated secondary antibodies and the Vectastain ABC-Kit (Vector Laboratories, Burlingame, CA, USA) protocols. Subsequently, the specimens were fixed in buffered glutaraldehyde and DAB precipitates were silver enhanced followed by 
Supplemental Results
Additional genetic findings
Patient 1 and her father (patient 2), both carriers of the p.Ala615del mutation in KIF11, also carried a heterozygous RP1L1 missense variant, c.329C>T (p.Pro110Leu) in Exon 2. It has previously been reported in a patient with occult macular dystrophy. 4 This RP1L1 allele has been documented in the general population, albeit with a minor allele frequency of 0.005% which would still be compatible with pathogenicity for an autosomal dominant mutation (cutoff of 0.1%).
However, the retinal phenotype in patients 1 and 2 were not compatible with occult macular dystrophy, but is in line with other patients with KIF11-associated retinopathy. Moreover, the asymptomatic father/mother of patient 2 also carried the RP1L1 variant. Thus, the RP1L1 variant unlikely contributes to the retinal phenotype in patients 1 and 2.
Patient 3 additionally carried a heterozygous splice site mutation, c.2944+1G>A, in GUCY2D; however, a second variant was not found by next-generation sequencing.
Additional copy number variations (CNVs) can largely be excluded because of an established and routinely performed CNV analysis based on quantitative readout of the NGS data. Biallelic loss-of-function mutations of GUCY2D cause Leber's congenitcal amaurosis, 5 whereas certain heterozygous missense variants cause autosomal dominant cone-rod dystrophy. 6 We consider the heterozygous GUCY2D splice site mutation in patient 3 as an incidentally identified carriership for autosomal recessive Leber's congenitcal amaurosis.
